Real-World Observational Study to Assess Drug Utilisation Patterns in the US Among Migraine Patients Treated with Lasmiditan (H8H-MC-B005)

First published 16/03/2023

Last updated 22/11/2024

EU PAS number:

EUPAS45442

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

B005 05 Protocol PASS(v0.1)_Redacted.pdf

English (4.43 MB - PDF)View document

Study results

Study report

Study report

LY573144 B005 Noninterventional PASS Final Study Report – Basic Version 1_Redacted.pdf

English (373.42 KB - PDF)View document

Other information

ENCePP Seal

ENCePP Seal documents